Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

MYCOF Mydecine Innovations

0.540
+0.030+5.88%
Close 09/30 16:00 ET
High
0.550
Open
0.400
Turnover
15.58K
Low
0.400
Pre Close
0.510
Volume
36.64K
Market Cap
4.90M
P/E(TTM)
Loss
52wk High
30.000
Shares
9.07M
P/E(Static)
Loss
52wk Low
0.050
Float Cap
4.40M
Bid/Ask %
0.00%
Historical High
110.000
Shs Float
8.15M
Volume Ratio
2.14
Historical Low
0.050
Dividend TTM
--
Div Yield TTM
--
P/B
-3.29
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.45%
Amplitude
29.41%
Avg Price
0.425
Lot Size
1
Float Cap
4.40M
Bid/Ask %
0.00%
Historical High
110.000
Shs Float
8.15M
Volume Ratio
2.14
Historical Low
0.050
Dividend TTM
--
P/B
-3.29
Dividend LFY
--
Turnover Ratio
0.45%
Amplitude
29.41%
Avg Price
0.425
Lot Size
1
Price Forecast

No Data

News

Comment

Company Overview More
Mydecine Innovations Group, Inc. operates as a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions. It encompasses three companies: Mindleap Health, Mydecine Health Sciences, and NeuroPharm Inc. The Mindleap Health is an advanced digital health platform that helps people connect with mental health specialists who can empower them to thrive and develop habits for a healthy mind. The Mydecine Health Sciences is a vertically integrated company developing novel fungtional mushroom products and psychedelic medicines for healthy and vulnerable populations. The NeuroPharm is developing a unique and proprietary set of pharmaceutical and natural health products addressing mental wellness in vulnerable populations. The company was founded by Parente Carman on September 27, 2013 and is headquartered in Vancouver, Canada.
CEO: --
Market: Pink Market
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...